Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, have been granted conditional marketing authorization (CMA) from the European Commission (EC) for their COVID-19 vaccine, making it the first COVID vaccine to receive a CMA in the...

The US Food and Drug Administration’s (FDA) has authorized the emergency use of Moderna’s vaccine against COVID-19 in individuals 18 years of age or older, making it the second vaccine against COVID-19 authorized for emergency use in the US. On...

Eli Lilly and Company has agreed to acquire Prevail Therapeutics, a New York-based company developing gene therapies, in a $1.04-billion deal ($880 million upfront plus one non-tradable contingent value right worth up to $160 million). The...

AstraZeneca has agreed to acquire Alexion Pharmaceuticals, a Boston-based biopharmaceutical company focused on rare diseases, for $39 billion. The acquisition would position AstraZeneca in immunology and the development of medicines for...